| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Bausch Health Companies Inc. (BHC) has 16 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. BHC is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 73.26M | $421.95M | - | |
| CEO | 2.92M | $16.83M | - | |
| VP | 637.5K | $3.67M | - | |
| Dir | 360.1K | $2.07M | - | |
| Dir | 266.4K | $1.53M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 5, 2023 | Carson Seana60 | EVP, General Counsel | Sell | 220 | $7.38 | $1,623.60 | - | +34.4% | +14.0% | |
| Nov 6, 2023 | Carson Seana60 | EVP, General Counsel | Sell | 43 | $7.61 | $327.23 | - | +4.3% | +30.1% | |
| Sep 6, 2023 | Carson Seana60 | EVP, General Counsel | Sell | 6,685 | $8.28 | $55,351.80 | -1.7% | -14.7% | -26.0% | |
| Feb 28, 2023 | Carson Seana60 | EVP, General Counsel | Sell | 292 | $9.32 | $2,721.44 | - | -12.0% | -1.2% | |
| Apr 14, 2022 | Spurr Robert82 | U.s. President-pharma Business | Sell | 1,595 | $22.19 | $35,393.05 | -1.7% | -59.4% | -66.2% | |
| Mar 15, 2022 | Spurr Robert82 | U.s. President-pharma Business | Sell | 4,846 | $22.20 | $107,581.20 | -5.0% | -65.5% | -65.3% | |
| Mar 8, 2022 | Gordon Joseph F77 | Pres&Co-head Bausch&Lomb/ Int'l | Sell | 3,889 | $21.76 | $84,624.64 | -4.0% | -57.4% | -60.1% | |
| Mar 2, 2022 | Gordon Joseph F77 | Pres&Co-head Bausch&Lomb/ Int'l | Sell | 11,077 | $23.37 | $258,869.49 | -9.9% | -59.8% | -61.7% | |
| Mar 2, 2022 | Spurr Robert82 | U.s. President-pharma Business | Sell | 1,595 | $23.37 | $37,275.15 | -2.4% | -59.8% | -61.7% | |
| Mar 1, 2022 | Gordon Joseph F77 | Pres&Co-head Bausch&Lomb/ Int'l | Sale+OE | 6,338 | $23.82 | $150,971.16 | -5.3% | -58.5% | -60.6% |